Reports of the opioid crisis or the opioid epidemic appear in the media on an almost daily basis.  Overdose deaths from another source have been steadily rising as well but have received very little media attention.  Benzodiazepines, once considered an extremely safe medication, are resulting in higher rates of drug addiction and are being implicated in overdose deaths, especially when used in conjunction with opioids.

The first benzodiazepine to hit the market was chlordiazepoxide marketed as Librium in 1960, followed by diazepam (Valium) in 1963.  Other medications joined the list of commonly prescribed benzodiazepine including alprazolam (Xanax), clobazam (Onfi), clonazepam (Klonopin), clorazepate (Tranxene), and lorazepam (Ativan).

Originally believed to be less toxic and less likely to cause dependence than older medications, the medical community embraced and prescribed benzodiazepines.

In the next several years the prescriptions for benzodiazepines continued to soar, and by the mid-1970s, they were at the top of the lists of most frequently prescribed medications with over 40 million prescriptions written annually.  Within the next decade, prescribers were becoming more aware of the addiction and abuse potential with benzodiazepines.

Still, most medical providers believed if their patients took the medication as prescribed and did not increase their dosage, they would have no problem with benzodiazepines.  In the 1980s researchers issued the first warnings about benzos after identifying that patients who stayed within their prescribed boundaries were having difficulty getting off the medication.

The number of prescriptions written is currently on the rise again.  A recent article on the JAMA Network (Journal of the American Medical Association) recognized that although prescriptions written by psychiatrists have remained relatively stable, benzodiazepine prescriptions had nearly doubled for both ambulatory care visits and visits to primary care physicians. Considering the increasing death rates associated with benzodiazepines, addressing prescribing patterns may help curb the growing use of benzodiazepines.

According to the Federal Drug Administration (FDA), the number of individuals who were prescribed both opioids and benzodiazepines grew by 41 percent, or 2.5 million, between 2002 and 2014.  In 2016 the FDA issued a “black box” warning, the strongest warning they can issue, to be placed on almost 400 products explaining that taking opioids and benzodiazepines together could result in coma, extreme sleepiness, slowed breathing and even death.

According to the National Institute on Drug Abuse, more than 30 percent of overdoses involving opioids also involve benzodiazepines.  These numbers prove that benzodiazepines should be prescribed cautiously by providers and patients should be made aware of the risks involved.

Gulf Breeze Recovery hopes to raise awareness of the potential risks of benzodiazepines, especially when combined with opioids so that negative consequences can be avoided.

Gulf Breeze Recovery is a holistic, non-12-step, drug and alcohol abuse treatment program that focuses not only on helping their guests achieve sobriety, but also helping them begin a healthy, happy lifestyle.

If you or someone you love is fighting addiction or has relapsed one or many times, help is available. Recovery is possible. We offer a compassionate and holistic treatment program. Contact us at Gulf Breeze Recovery or call: 833.551.2356 to speak to an addiction expert to learn more about our program that has helped so many people overcome their addiction, rediscover their dreams and embrace life.

We help people not just to survive, but to THRIVE®